Arterial [bpoc]
Venous [bpoc]
Thromboembolic events [patf]
anti-TNF therapy [topp]
Study [mnob]
Spontaneous Report [inpr]
Background [cnce]
Systemic [ftcn]
Inflammation [patf]
Rheumatoid Arthritis [dsyn]
Crohn Disease [dsyn]
CD [idcn]
Responsible [fndg]
vascular [bpoc]
Comorbidity [idcn]
tnf alpha [aapp, imft]
Blockade [ftcn]
Expected [idcn]
To [qlco]
Lower [spco]
Comorbidities [idcn]
Several [qnco]
Cases [ftcn]
Arterial [bpoc]
Venous [bpoc]
Thromboembolic events [patf]
Reported [inpr]
objectives [inpr]
Aim [idcn]
Work [ocac]
To [qlco]
Study [mnob]
Main [qlco]
Characteristics [qlco]
Notify [hlca]
TNF [aapp, imft]
alpha blockers [phsu]
Thromboembolic events [patf]
Methods [inpr]
Thromboembolic events [patf]
infliximab [aapp, imft, phsu]
Etanercept [aapp, imft, phsu]
adalimumab [aapp, imft, phsu]
Notify [hlca]
French [popg]
Adverse Drug Report [inpr]
System [ftcn]
Database [inpr]
Analyzed [resa]
Separate [spco]
Analysis [lbpr]
Arterial [bpoc]
Thromboembolic events [patf]
Venous [bpoc]
Thromboembolic events [patf]
Performed [ftcn]
risk factors [qnco]
Category [inpr]
Thromboembolic events [patf]
Assessed [acty]
criteria [inpr]
Result [ftcn]
Thromboembolic events [patf]
Analyzed [resa]
Represent [acty]
Notify [hlca]
Adverse reactions [fndg]
TNF [aapp, imft]
alpha blockers [phsu]
Database [inpr]
Arterial [bpoc]
Events [evnt]
Venous [bpoc]
Events [evnt]
Incidence [qnco]
Not [ftcn]
Different [qlco]
TNF [aapp, imft]
alpha blockers [phsu]
Mean [qnco]
Delay [tmco]
Thromboembolic events [patf]
Onset [qlco]
treatment [ftcn]
Initiation [menp]
months [tmco]
short [qlco]
Etanercept [aapp, imft, phsu]
months [tmco]
P NOS [aapp, imft]
Venous [bpoc]
Thromboembolic events [patf]
Patients [podg]
Arterial [bpoc]
Thromboembolic events [patf]
More [ftcn]
risk factors [qnco]
Patients [podg]
Venous [bpoc]
Thromboembolic events [patf]
RF [aapp, imft]
Only [qnco]
One [qnco]
Most [qnco]
Patients [podg]
Received [qlco]
Concomitant [tmco]
Systemic [ftcn]
Corticosteroids [horm, phsu, strd]
Methotrexate [orch, phsu]
Patients [podg]
investigated [ftcn]
Autoimmunity [patf]
Antiphospholipid Antibodies [aapp, imft]
Main [qlco]
limitations [ftcn]
Study [mnob]
Heterogeneous [qlco]
Report [inpr]
Contents [cnce]
Conclusion [idcn]
limitations [ftcn]
Study [mnob]
Suggest [idcn]
Venous [bpoc]
Thromboembolic events [patf]
therapy, TNF [topp]
alpha blockers [phsu]
Occurred [acty]
Patients [podg]
Few [qnco]
risk factors [qnco]
Venous Thrombosis [patf]
Needs [qlco]
More [ftcn]
Evaluated [ftcn]
Controlled Study [resa]
